Sales decline 10.62% to Rs 66.98 crore
Net profit of Hester Biosciences declined 64.43% to Rs 3.98 crore in the quarter ended December 2023 as against Rs 11.19 crore during the previous quarter ended December 2022. Sales declined 10.62% to Rs 66.98 crore in the quarter ended December 2023 as against Rs 74.94 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales66.9874.94 -11 OPM %15.1525.03 -PBDT10.1621.24 -52 PBT6.4116.00 -60 NP3.9811.19 -64Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content